It’s always an honor to represent NIH before members of Congress. On April 19, I did so before the U.S. House of Representatives’ Labor, Health and Human Services, Education subcommittee. I was invited to testify as part of the subcommittee’s FY24 Budget and Oversight Hearing for the Administration for Strategic Preparedness & Response (ASPR), Centers for Disease Control and Prevention (CDC), and NIH. Also invited to testify were Dawn O’Connell, Assistant Secretary of ASPR; and Rochelle Walensky, director of CDC. During the hearing, I had a chance to answer many questions and to share with the subcommittee members how NIH-supported discoveries have impacted nearly all of our lives—from research studies that lay the foundation for future biomedical advances to clinical trials that evaluate potentially lifesaving interventions. The hearing was held in the Rayburn House Office Building in Washington, D.C. Credit: NIH
On May 11, I was pleased to appear before the U.S. House of Representatives Subcommittee on Labor, Health and Human Services, Education, and Related Agencies to discuss NIH’s budget request for Fiscal Year 2023. Joining me (left to right) were leaders of several NIH institutes: Nora Volkow, National Institute on Drug Abuse; Tony Fauci, National Institute of Allergy and Infectious Diseases; Diana Bianchi, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Doug Lowy, National Cancer Institute; and Gary Gibbons, National Heart, Lung, and Blood Institute.
Great to see Frank Stephens at a hearing on NIH’s budget for Fiscal Year 2020! As I told the House Labor/HHS Appropriations Subcommittee on April 2, 2019, I’m inspired by his advocacy for research that will benefit people with Down syndrome and many other diseases. Credit: NIH
On April 2, 2019, I testified before the House Labor/HHS Appropriations Subcommittee on NIH’s budget for Fiscal Year 2020. Here I am waiting for the hearing to start with my colleagues (left to right) Gary Gibbons, director of the National Heart, Lung, and Blood Institute; Diana Bianchi, director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; and Anthony Fauci, director of National Institute of Allergy and Infectious Diseases. Credit: NIH
